Sec Form 4 Filing - Hippel James @ BIO-TECHNE Corp - 2016-03-31

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Hippel James 2. Issuer Name and Ticker or Trading Symbol BIO-TECHNE Corp [ TECH] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) 614 MCKINLEY PLACE N.E. 3. Date of Earliest Transaction (MM/DD/YY) 03/31/2016 (Street) MINNEAPOLIS, MN55413 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/31/2016 M 1,666 A 6,100 ( 2 ) D Common Stock 03/31/2016 F 556 D $ 94.52 5,544 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Units ( 1 ) 03/31/2016 M 1,666 ( 3 ) ( 3 ) Common Stock 1,666 $ 0 1,667 D Restricted Stock Units ( 1 ) ( 4 ) ( 4 ) Common Stock 3,000 3,000 D Stock Options (Right to Buy) $ 108.49 ( 4 ) 08/07/2022 Common Stock 12,500 12,500 D Stock Options (Right to buy) $ 108.49 ( 5 ) 08/07/2022 Common Stock 25,000 25,000 D Stock Options (Right to Buy) $ 94.35 ( 6 ) 08/12/2021 Common Stock 35,000 35,000 D Stock Options (Right to Buy) $ 86.25 ( 7 ) 04/01/2021 Common Stock 10,000 10,000 D Stock Options (Right to buy) $ 86.25 ( 8 ) 04/01/2021 Common Stock 25,000 25,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Hippel James 614 MCKINLEY PLACE N.E. MINNEAPOLIS, MN55413 Chief Financial Officer Signatures /s/ Elizabeth M. Dunshee as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed. 04/04/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. ( 2 )Includes 1,667 shares of restricted stock units that vest on 3/31/2017 (previously reported on Table II). ( 3 )On April 1, 2014, the reporting person was granted 5,000 restricted stock units, vesting in three equal annual installments beginning on March 31,2015. ( 4 )Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years. ( 5 )6,250 shares vest on each of 8/7/2016, 8/7/2017, 8/7/2018 and 8/7/2019. ( 6 )8,750 shares vest on each of 8/12/2015, 8/12/2016, 8/12/2017 and 8/12/2018. ( 7 )Vests in full or in part if certain performance goals are achieved. ( 8 )6,250 shares vest on each of 4/1/2015, 4/1/2016, 4/1/2017 and 4/1/2018.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.